Skip to Content
Merck
CN
  • Molecular characterization of Rifr mutations in Enterococcus faecalis and Enterococcus faecium.

Molecular characterization of Rifr mutations in Enterococcus faecalis and Enterococcus faecium.

Journal of chemotherapy (Florence, Italy) (2013-09-28)
Xiaoxing Du, Xiaoting Hua, Tingting Qu, Yan Jiang, Zhihui Zhou, Yunsong Yu
ABSTRACT

Mutation rate is an important factor affecting the appearance and spread of acquired antibiotic resistance. The frequencies and types of enterococci mutations were determined in this study. The MICs of rifampicin in enterococci and their rifampicin-resistant mutants were determined by the Clinical and Laboratory Standards Institute (CLSI) agar dilution method. The Enterococcus faecalis isolates A15 and 18165 showed no significant differences in mutation frequencies or mutation rates. In Enterococcus faecium, the mutation frequency and mutation rate were both 6·4-fold lower than in E. faecalis. The spectrum of mutations characterized in E. faecium B42 differed significantly from that of E. faecalis. The types and rate of mutations indicated that E. faecalis had a higher potential to develop linezolid resistance. Rifampicin resistance was associated with mutations in the rpoB gene. Rifampicin MICs for the E. faecalis mutant were 2048 mg/l, but rifampicin MICs for E. faecium mutants ranged from 64 to 1024 mg/l.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Rifampicin, ≥95% (HPLC), powder or crystals
Sigma-Aldrich
Rifampicin, suitable for plant cell culture, BioReagent, ≥95% (HPLC), powder or crystals
Rifampicin, European Pharmacopoeia (EP) Reference Standard